Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Non-Current Deferred Tax Liability (2025)

Basel Medical (BMGL) posted Non-Current Deferred Tax Liability of $29902.5 for Q4 2025, down 68.56% sequentially from $95116.6 in Q2 2025.

Analysis

Basel Medical (BMGL) Non-Current Deferred Tax Liability (2025) Analysis & Trends

Basel Medical has reported Non-Current Deferred Tax Liability for 1 years, with the latest figure at $29902.5 in Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $29902.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29902.5 (changed N/A YoY) and the FY2025 annual result came in at $93447.4, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability eased to $29902.5 in Q4 2025 per BMGL's latest filing, from $95116.6 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $95116.6 in Q2 2025 and troughed at $29902.5 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 89.32 Bn 88.30 Bn 15.19 Bn
2 Tenet Healthcare 22.14 Bn 19.97 Bn 4.45 Bn
3 Encompass Health 12.05 Bn 11.91 Bn 1.34 Bn
4 Davita 11.89 Bn 11.21 Bn 1.16 Bn
5 Universal Health Services 10.10 Bn 9.96 Bn 3.29 Bn
6 Ensign 9.89 Bn 9.57 Bn 306.24 Mn
7 Chemed 6.85 Bn 6.81 Bn 221.47 Mn
8 Pacs 6.75 Bn 6.59 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.31 Bn 4.15 Bn 192.10 Mn
10 Basel Medical 7.33 Mn 6.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 29,902.50
Jun 30, 2025 95,116.56